Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2024

Open Access 01-12-2024 | Obesity | Research

Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel

Authors: Sethapong Lertsakulbunlue, Tanatip Sangkool, Varathpavee Bhuriveth, Mathirut Mungthin, Ram Rangsin, Anupong Kantiwong, Boonsub Sakboonyarat

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

Hyperuricemia has placed an immense burden on the global healthcare system. Studies have discovered a close correlation between serum uric acid (SUA) and insulin resistance (IR). The objective of this investigation is to examine the association between the triglyceride-glucose (TyG) index, a simple surrogate for IR, and the presence of hyperuricemia.

Methods

Between 2017 and 2021, an epidemiologic study was conducted on Royal Thai Army (RTA) personnel aged 35–60 years, involving a total of 231,286 participants. In the study, hyperuricemia was defined as a SUA level of 7 mg/dL and 6 mg/dL among male and female participants, respectively. Using linear regression analysis and logistic regression analysis, the association between the TyG index and SUA was determined.

Results

A positive relationship was demonstrated between the TyG index and the SUA. Overall, SUA increased by 0.32 per unit of TyG index growth (95% CI: 0.31–0.32). In comparison with the first quartile, employees in the fourth TyG quartile had a greater likelihood of having hyperuricemia [adjusted odds ratio (AOR): 2.45, 95% CI: 2.38–2.52]. Effect modification by obesity on the association between the TyG index and SUA was observed (P-interaction < 0.001). Among individuals with obesity, compared with the first TyG index quartile, the AOR for hyperuricemia was 2.15 (95% CI: 2.06–2.25) and 2.14 (95% CI: 1.81–2.53) for the fourth quartile of the TyG index for males and females, respectively. However, for nonobese personnel, in comparison to the top quartile of the TyG index, the AOR for hyperuricemia was 2.73 (95% CI:2.61–2.84) and 5.03 (95% CI: 4.03–6.29) for the fourth quartile of the TyG index for males and females, respectively. Personnel in the fourth TyG index quartile revealed that the prevalence of hyperuricemia reached 44.2%.

Conclusion

A robust positive association between the TyG index and SUA was illustrated among active-duty RTA personnel. Obesity was identified as a modifier influencing this relationship. Furthermore, individuals in the fourth quarter of the TyG index, regardless of their obesity status, could be considered appropriate candidates for screening SUA levels.
Appendix
Available only for authorised users
Literature
1.
Hou Y, Yang X, Wang C, Zhi L, Yang M, You C. Hypertriglyceridemia and hyperuricemia: a retrospective study of urban residents. Lipids Health Dis. 2019;18:81.PubMedPubMedCentralCrossRef
2.
Zhang Q, Li H, Xing D, Lin J. Global research trends in hyperuricemia: a bibliometric and visualized study. Mod Rheumatol. 2022;32:619–25.PubMedCrossRef
3.
Li Y, You A, Tomlinson B, Yue L, Zhao K, Fan H, et al. Insulin resistance surrogates predict hypertension plus hyperuricemia. J Diabetes Investig. 2021;12:2046–53.PubMedPubMedCentralCrossRef
4.
5.
Din SE, Salem UAA, Abdulazim MM. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review. J Adv Res. 2017;8:537–48.CrossRef
6.
7.
Lee J-M, Kim HC, Cho HM, Oh SM, Choi DP, Suh I. Association between serum uric acid level and metabolic syndrome. J Prev Med Public Health. 2012;45:181–7.PubMedPubMedCentralCrossRef
8.
Wang H, Zhang H, Sun L, Guo W. Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases. Am J Transl Res. 2018;10(9):2749–63. Published 2018 Sep 15.PubMedPubMedCentral
9.
10.
Tao L-C, Xu J, Wang T, Hua F, Li J-J. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21:68.PubMedPubMedCentralCrossRef
11.
Luo Y, Hao J, He X, Wang C, Zhao H, Zhang Z, et al. Association between triglyceride-glucose index and serum uric acid levels: a biochemical study on Anthropometry in non-obese type 2 diabetes Mellitus patients. Diabetes Metab Syndr Obes. 2022;15:3447–58.PubMedPubMedCentralCrossRef
12.
Zhou S, Yu Y, Zhang Z, Ma L, Wang C, Yang M et al. Association of obesity, triglyceride-glucose and its derivatives index with risk of hyperuricemia among college students in Qingdao, China. Front Endocrinol (Lausanne). 2022;13.
13.
Li Q, Shao X, Zhou S, Cui Z, Liu H, Wang T, et al. Triglyceride-glucose index is significantly associated with the risk of hyperuricemia in patients with diabetic kidney disease. Sci Rep. 2022;12:19988.PubMedPubMedCentralCrossRef
14.
Kahaer M, Zhang B, Chen W, Liang M, He Y, Chen M et al. Triglyceride Glucose Index Is More Closely Related to Hyperuricemia Than Obesity Indices in the Medical Checkup Population in Xinjiang, China. Front Endocrinol (Lausanne). 2022;13.
15.
Lertsakulbunlue S, Mungthin M, Rangsin R, Kantiwong A, Sakboonyarat B. Relationship between triglyceride-glucose index and aminotransferase among Royal Thai Army personnel 2017–2021: a serial cross-sectional study. Lipids Health Dis. 2023;22:47.PubMedPubMedCentralCrossRef
16.
Klongthalay S, Kanjana Suriyaprom. Increased uric acid and life style factors Associated with metabolic syndrome in Thais. Ethiop J Health Sci. 2020;30.
17.
Jaipakdee J, Jiamjarasrangsri W, Lohsoonthorn V, Lertmaharit S. Prevalence of metabolic syndrome and its association with serum uric acid levels in Bangkok Thailand. Southeast Asian J Trop Med Public Health. 2013;44:512–22.PubMed
18.
Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Rising trends in obesity prevalence among Royal Thai Army personnel from 2017 to 2021. Sci Rep. 2022;12:7726.PubMedPubMedCentralCrossRef
19.
Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Prevalence of hypertriglyceridemia among Royal Thai Army personnel and its related cardiometabolic risk factors, from 2017 to 2021. BMC Public Health. 2022;22:1569.PubMedPubMedCentralCrossRef
20.
Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78:51–7.PubMedCrossRef
21.
Linden A, Mathur MB, VanderWeele TJ. Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: the evalue package. The Stata Journal: Promoting Communications on Statistics and Stata. 2020;20:162–75.CrossRef
22.
Sakboonyarat B, Poovieng J, Sangkool T, Lertsakulbunlue S, Jongcherdchootrakul K, Srisawat P et al. Relationship between pulse pressure and body mass index in active-duty Royal Thai Army personnel in Thailand. BMC Cardiovasc Disord. 2023;23.
23.
24.
Sakboonyarat B, Poovieng J, Lertsakulbunlue S, Jongcherdchootrakul K, Srisawat P, Mungthin M, et al. Association between raised blood pressure and elevated serum liver enzymes among active-duty Royal Thai Army personnel in Thailand. BMC Cardiovasc Disord. 2023;23:143.PubMedPubMedCentralCrossRef
25.
Lertsakulbunlue S, Mungthin M, Rangsin R, Kantiwong A, Sakboonyarat B. Trends in predicted 10-year risk for cardiovascular diseases among patients with type 2 diabetes in Thailand, from 2014 to 2018. BMC Cardiovasc Disord. 2023;23:183.PubMedPubMedCentralCrossRef
26.
Li C, Hsieh M-C, Chang S-J. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25:210–6.PubMedCrossRef
27.
Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45:145–54.PubMedCrossRef
28.
Furuhashi M, Matsumoto M, Murase T, Nakamura T, Higashiura Y, Koyama M, et al. Independent links between plasma xanthine oxidoreductase activity and levels of adipokines. J Diabetes Investig. 2019;10:1059–67.PubMedPubMedCentralCrossRef
29.
Toyoki D, Shibata S, Kuribayashi-Okuma E, Xu N, Ishizawa K, Hosoyamada M, et al. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. Am J Physiology-Renal Physiol. 2017;313:F826–34.CrossRef
30.
Gu Q, Hu X, Meng J, Ge J, Wang SJ, Liu XZ. Associations of triglyceride-glucose index and its derivatives with hyperuricemia risk: a Cohort Study in Chinese General Population. Int J Endocrinol. 2020;2020:1–7.
31.
Shi W, Xing L, Jing L, Tian Y, Liu S. Usefulness of triglyceride-glucose index for estimating Hyperuricemia risk: insights from a general Population. Postgrad Med. 2019;131:348–56.PubMedCrossRef
32.
Mazidi M, Katsiki N, Mikhailidis DP, Banach M. The link between insulin resistance parameters and serum uric acid is mediated by adiposity. Atherosclerosis. 2018;270:180–6.PubMedCrossRef
33.
Zou S, Yang C, Shen R, Wei X, Gong J, Pan Y et al. Association between the triglyceride–glucose index and the incidence of diabetes in people with different phenotypes of obesity: a retrospective study. Front Endocrinol (Lausanne). 2021;12.
34.
Larsson SC, Burgess S, Michaëlsson K. Genetic association between adiposity and gout: a mendelian randomization study. Rheumatology. 2018;57:2145–8.PubMedCrossRef
35.
Choi Y-J, Shin H-S, Choi HS, Park J-W, Jo I, Oh E-S, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest. 2014;94:1114–25.PubMedCrossRef
36.
Gong M, Wen S, Nguyen T, Wang C, Jin J, Zhou L. Converging relationships of obesity and hyperuricemia with Special Reference to Metabolic disorders and plausible therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:943–62.PubMedPubMedCentralCrossRef
37.
38.
Choi HK, Atkinson K, Karlson EW, Curhan G, Obesity. Weight change, hypertension, Diuretic Use, and risk of gout in men. Arch Intern Med. 2005;165:742.PubMedCrossRef
39.
Jiang J, Cai X, Pan Y, Du X, Zhu H, Yang X, et al. Relationship of obesity to adipose tissue insulin resistance. BMJ Open Diabetes Res Care. 2020;8:e000741.PubMedPubMedCentralCrossRef
40.
Lessard J, Laforest S, Pelletier M, Leboeuf M, Blackburn L, Tchernof A. Low abdominal subcutaneous preadipocyte adipogenesis is associated with visceral obesity, visceral adipocyte hypertrophy, and a dysmetabolic state. Adipocyte. 2014;3:197–205.PubMedPubMedCentralCrossRef
41.
42.
Clamp LD, Hume DJ, Lambert EV, Kroff J. Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history. Nutr Diabetes. 2017;7:e282–2.PubMedPubMedCentralCrossRef
43.
Xuan W, Liu D, Zhong J, Luo H, Zhang X. Impacts of Triglyceride Glucose-Waist to Height Ratio on Diabetes Incidence: A Secondary Analysis of A Population-Based Longitudinal Data. Front Endocrinol (Lausanne). 2022;13.
44.
Mirr M, Skrypnik D, Bogdański P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021;44:2831–43.PubMedPubMedCentralCrossRef
45.
Shi J-C, Chen X-H, Yang Q, Wang C-M, Huang Q, Shen Y-M, et al. A simple prediction model of hyperuricemia for use in a rural setting. Sci Rep. 2021;11:23300.PubMedPubMedCentralCrossRef
46.
Brucato A, Cianci F, Carnovale C. Management of hyperuricemia in asymptomatic patients: a critical appraisal. Eur J Intern Med. 2020;74:8–17.PubMedCrossRef
47.
Valsaraj R, Singh AK, Gangopadhyay KK, Ghoshdastidar B, Goyal G, Batin M, et al. Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14:93–100.
48.
Yu C, Wang T, Zhou W, Zhu L, Huang X, Bao H, et al. Positive association between the triglyceride-glucose index and Hyperuricemia in Chinese adults with hypertension: an insight from the China H-Type Hypertension Registry Study. Int J Endocrinol. 2022;2022:1–8.CrossRef
49.
Qi J, Ren X, Hou Y, Zhang Y, Zhang Y, Tan E et al. Triglyceride-Glucose Index is Significantly Associated with the Risk of Hyperuricemia in Patients with Nonalcoholic Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity. 2023;Volume 16:1323–34.
50.
Wu J, Qiu L, Cheng X, Xu T, Wu W, Zeng X, et al. Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population. Sci Rep. 2017;7:5456.PubMedPubMedCentralCrossRef
Metadata
Title
Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel
Authors
Sethapong Lertsakulbunlue
Tanatip Sangkool
Varathpavee Bhuriveth
Mathirut Mungthin
Ram Rangsin
Anupong Kantiwong
Boonsub Sakboonyarat
Publication date
01-12-2024
Publisher
BioMed Central
Keywords
Obesity
Obesity
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01542-3

Other articles of this Issue 1/2024

BMC Endocrine Disorders 1/2024 Go to the issue

Research

Effect of metformin on anti-mullerian hormone levels in women with polycystic ovarian syndrome: a systematic review and meta-regression analysis of randomized controlled trials with

Research

L-shaped association between the GA/HbA1c ratio and all-cause mortality in U.S. adults with NAFLD: a cross-sectional study from the NHANES 1999–2004

Research

Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT

Research

Socio-behavioral determinants of health-related quality of life among patients with type 2 diabetes: comparison between 2015 and 2018

Research

Correlation between insulin resistance and the rate of neutrophils-lymphocytes, monocytes-lymphocytes, platelets-lymphocytes in type 2 diabetic patients

Research

Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits